Wang Bisheng, commander of the epidemic command center, said that the vaccine purchase plan for next year will still focus on mRNA vaccines, supplemented by secondary protein vaccines.

(Associated Press file photo)

[Reporter Wu Liangyi/Report from Taipei] The local epidemic of pneumonia in Wuhan has begun to heat up again, and whether to purchase BNT next-generation vaccine has recently become controversial again.

The Central Epidemic Command Center announced the latest vaccine inventory yesterday. There are still 3.14 million doses of the Moderna next-generation vaccine, 270,000 doses of the infant dosage form, and 3.09 million doses of the BNT monovalent vaccine.

The vaccine purchase plan for next year will still focus on mRNA vaccines, supplemented by protein vaccines. Commander Wang Bisheng emphasized that Taiwan has never rejected BNT vaccines.

Purchasing is smoother.

Moderna's next-generation inventory is 3.14 million doses

my country's current vaccination is dominated by Moderna's next-generation bivalent vaccine, with 314,000 doses left, 270,000 doses for infants, and 320,000 doses of the subunit protein vaccine NOVAVAX.

In the past month, an average of 28,598 people were inoculated every day.

Please read on...

As for the vaccine plan for next year, Wang Bisheng, commander of the command center, said that the mRNA next-generation vaccine will be the main one, and an appropriate amount of subunit protein vaccine will be provided.

The latest vaccine will be obtained as soon as possible, and the appropriate dose and interval will be evaluated to make the Wuhan pneumonia vaccine "normalized".

3.09 million doses of BNT monovalent vaccine left

Recently, the procurement of BNT vaccine has sparked another controversy. Wang Bisheng explained yesterday that there are still about 3.09 million doses of the BNT monovalent vaccine previously purchased in my country, and the next generation of BNT vaccine needs to be repurchased. BNT has purchased nearly 23 million doses of vaccines, and believes that Taiwan is worthwhile for BNT to set up a branch in Taiwan or find a Taiwan agent instead of handing it over to a foreign agent.

Wang Bisheng pointed out that Taiwan has purchased 26 million doses of the Moderna vaccine. Moderna has set up a branch in Taiwan. Last week, the delivery was discussed. The branch immediately sent people to the command center and was authorized by its headquarters to make decisions. , It is very helpful to Taiwan. It has a contract with Moderna for 20 million doses this year and 15 million doses next year. It retains flexibility and can change to the latest vaccine at any time.

Wang Bisheng sincerely said yesterday: "I sincerely suggest that BNT Company consider setting up a branch in Taiwan, or if the market is really too small and unwilling to set up a branch, whether to act as an agent for our domestic agents, not for foreign agents. Business agent." He emphasized that we have never ruled out the next generation of BNT, and hope that the future cooperation will be smoother.

It is reported that although Shanghai Fosun, the agent of the German BNT vaccine, is a Chinese company, the BNT vaccine cannot be sold to China at present, but can only be sold to Hong Kong, Macau and Taiwan.

A few days ago, Macau opened up vaccinations for short-term tourists, that is, a large number of Chinese people went to get the BNT vaccine that has not yet been approved by the Chinese authorities (called Fubitai in China, Hong Kong and Macau).